The pharmaceutical landscape in the Middle East and North Africa (MENA) region is undergoing a rapid transformation, and Saudi Arabia is firmly at its helm. With its proactive regulatory framework, ambitious Vision 2030 objectives, and substantial investment in local production, the Kingdom is shaping the future of the region’s pharma industry. Smart pharmaceutical companies and
